Gilead Science (GILD) Followers Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Gilead Science (GILD) Followers

GILD 125.67

+0.4%

9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (951)	4/29/2020 12:27:40 PM
From: Wildbiftek	Read Replies (2) of 961

Not what I'm hearing: Anthony Fauci, the head of NIAID and the government’s top infectious-disease specialist, said at a White House meeting with President Donald Trump and Louisiana Governor John Bel Edwards that the trial showed a significant positive effect on the virus and that the results “were quite good news.” ... Fauci called the study the “first truly high-powered randomized placebo-controlled trial” of remdesivir. google.com NEW: Dr. Anthony Fauci said at the White House that data on Gilead's remdesivir show "clear cut significant positive effect in diminishing the time to recovery" and shows the "drug can block the virus." twitter.com Note that there's no actual data from the NIH study he's talking about yet. Data today were from a separate GILD sponsored trial comparing 5 vs 10 day regiment. It's hopeful since the 5 day regimen seems to work as well if not better than the 10, and this may mean more capacity to treat patients.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next